Global Hemp Group Inc. News Releases

Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing

Thu, 09 Oct 2025 09:29:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG0) ("GHG" or the "Company") announces that it has applied to the British Columbia Securities Commission ("BCSC") for a partial revocation order (the "Partial Revocation Order") in connection with the failure-to-file cease trade order ("FFCTO") issued against the Company on April 15, 2025, for failing to file certain continuous disclosure documents (collectively, the...

Global Hemp Group Announces Private Placement and Corporate Update

Tue, 18 Mar 2025 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 18, 2025) - Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement of up to 14,000,000 units (each a "Unit") at $0.031 per Unit for gross proceeds of up to $434,000 (the "Offering"). Each Unit is comprised of one common share in the capital of the Company (each a "Common Share") and one non-transferable Common Share purchase...

Global Hemp Group Announces Execution of Exclusive Option Agreement to Acquire Serres Theriault (2021) Inc. ("STI"), a Multi-Facetted, Vertically Integrated Cannabis Operator in New Brunswick and Announces Private Placement

Mon, 15 Jan 2024 11:50:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - January 15, 2024) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG0) ("GHG" or the "Company") is pleased to announce that it has executed an Exclusive Option Agreement (the "Agreement") to acquire Serres Thériault (2021) Inc. ("STI"), a multi-facetted vertically integrated cannabis operator in News Brunswick.This transaction provides the Company a clear pathway to further diversify its activities in the industry and importantly,...

Global Hemp Group Concludes First U.S. Sublicense Related to Its Recently Acquired Exclusive North American License of Apollon Formularies IP

Fri, 28 Apr 2023 07:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 28, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that the Company has executed the first North American sublicense for sales and revenue generation in the United States, relating to the recently acquired exclusive license to Apollon Formularies plc's ("Apollon") patents and IP.Global Hemp Group, Inc. issued a Non-Exclusive Sublicense to Medicinal One, LLC, a Florida...

Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property

Tue, 04 Apr 2023 11:35:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that it has completed its contractual obligations relating to the first stage of the binding Letter of Intent ("LOI") and the Exclusive Licensing Agreement for the patents and Intellectual Property ("IP") of Apollon Formularies plc ("Apollon"), by advancing a final payment of US$150,000 to Apollon (for further information...

Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor

Thu, 30 Mar 2023 09:25:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 30, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that Jeff Nagel has joined the Company's Advisory Board as its Product Manufacturing Advisor.Mr. Nagel is a veteran in the natural biologics drug discovery and manufacturing space, with more than 15 years' experience in the industry. He brings with him a wealth of knowledge and expertise that will be invaluable to Global...

Global Hemp Group Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at MD Anderson Cancer Center, as Its Chief Scientific Advisor

Wed, 22 Mar 2023 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce the appointment of Dr. Herbert Fritsche to the Company's Advisory Board as its Chief Scientific Advisor. Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas MD Anderson Cancer Center for 41 years.Dr. Fritsche...

Global Hemp Group Adds Israel, the European Union and Morocco as Exclusive Global Licenses from Apollon Formularies, PLC

Tue, 21 Mar 2023 09:24:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 21, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") announces that the Company has now added additional exclusive global licenses for the countries of Israel, and the European Union (with extension to Morocco) from Apollon Formularies, plc. These new exclusive licenses are in addition to the previously announced exclusive licenses for the United States, Canada, and Mexico with the same exclusive...

Global Hemp Group Announces Stephen D. Barnhill Jr. Has Been Appointed Interim President & CEO

Mon, 20 Mar 2023 11:36:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") announces that Stephen D. Barnhill Jr. has been appointed interim President & CEO effective immediately. Curt Huber, former President & CEO will remain as a Director of the Company and will oversee GHG's continuing industrial hemp related business segments.Mr. Barnhill is currently the Chief Operating Officer (COO) of Apollon Formularies, plc, a...